BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Policy

  Genmab and Janssen Head to Arbitration Table Over Darzalex Royalties

  In a brief statement, Genmab said it initiated binding arbitration related to two matters under its Darzalex (daratumumab) license agreement with Janssen Biotech.

  September 23, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  BioSpace Global Roundup, Sept. 24

  Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

  September 23, 2020

   · 

  8 min read

   · 

  Alex Keown
• 

  Biotech Beach

  Locanabio’s RNA-Targeting Gene Therapy May Offer Durable Response for DM1 Patients

  RNA-binding proteins are emerging as the next generation of molecular medicine.

  September 23, 2020

   · 

  3 min read

   · 

  Gail Dutton
• 

  Career Advice

  4 Things You Might Overlook When Applying for Jobs

  Often times, you can fall into a trap of seeing a particular title, skimming a listing, and firing off an application.

  September 23, 2020

   · 

  2 min read

   · 

  Laura Brothers
• 

  Policy

  FDA Plans New, More Stringent Guidance for COVID-19 Vaccine EUA

  Although the updated guidance has largely remained under wraps, sources who spoke to The Washington Post hinted that the new rules would make it more difficult for an EUA to be granted to a vaccine ahead of Nov. 3, the day of the U.S. elections.

  September 23, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  J&J’s One-Dose COVID-19 Vaccine Candidate Begins Phase III Trial

  The J&J vaccine appears to require only a single dose. Several of the other candidate vaccines require two doses about 28 days apart.

  September 23, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Evergreen Theragnostics Breaks Ground on Radiopharmaceutical Factory

  The new facility will be 14,000 square feet and is designed from start to finish to meet global current Good Manufacturing Practice (cGMP) standards for radiopharmaceutical manufacturing.

  September 23, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Another One Down: AC Immune and Genentech’s Tau Drug Fails Alzheimer’s Trial

  The drug failed to meet its primary efficacy endpoint, as well as two secondary endpoints.

  September 23, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Could Glycans Hold the Key to Attacking Coronavirus at its Source?

  A study published today showed that researchers have discovered an active role for glycans, the sugar molecules that decorate proteins. In turn, there may be new targets for certain therapies, and this could help experts looking to develop a vaccine for COVID-19.

  September 23, 2020

   · 

  2 min read

   · 

  Krystle Vermes
• 

  Biotech Beach

  ‘New Kid on the Block’ Libra Raises $29 Million to Tackle Neurodegenerative Diseases

  CEO Isaac Veinbergs has big hopes for the company’s unique approach to take on neurodegeneration through cellular cleaning.

  September 23, 2020

   · 

  3 min read

   · 

  Kate Goodwin